OSM and neoplasm: In contrast, injection of the same cells into Osm−/− mice results in a significantly reduced tumour burden, shown by iRFP intensity, tumour volume and tumour weight (Fig. 7a), demonstrating a systemic role for OSM in primary tumour growth.